Can CBD help Alzheimer's patients?
As the most common form of dementia, Alzheimer’s disease accounts for 60% to 80% of all dementia cases. Although Alzheimer’s and Parkinson’s are not part of normal aging the majority of individuals affected are 65 or older.
Research has shown potential benefits from CBD administered to dementia patients.
Currently there is no cure for Alzheimer’s, Parkinson’s or Huntington’s and there are very few treatments for symptoms. That said, significant research efforts are continuing and this research includes CBD (cannabiniol).
CBD has shown its potential to affect the body’s endocannibinoid system activating anti-inflammatory and other healing responses so it is not surprising that CBD has shown promising results in Alzheimer’s, Huntington’s and Parkinson’s research.
Listed below are links to published research trials that have considered CBD (cannabinoil) in treating the symptoms of dementia related illnesses. These research efforts have identified the potential benefits of CBD. This information can help you to decide if CBD is an option for you. You will also see organic, pure CBD products recommended.
Using CBD (Cannabidiol) to Treat the Symptoms of Alzheimer’s & Other Dementias
Dementia Care Central, February 2020
According to researchers at California’s Salk Institute, their 2017 study has found evidence that cannabinoids such as CBD could help remove dementia from, and increase connections between, brain cells. Those results were validated by other laboratories. While the US Food and Drug Administration has yet to approve a CBD drug for the purposes of treating dementia, it has approved a CBD-based drug for treating epilepsy.
CBD: A Natural Remedy that Decreases Symptomatic Behaviors of Parkinson’s Disease? Dementia Care Central, February 2020
A healthy, natural alternative to traditional medications is becoming more and more accessible for persons suffering the effects of Parkinson’s disease. Studies show that CBD, a Cannabidiol also referred to as CBD-rich cannabis, may relieve debilitating symptoms of Parkinson’s.
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
British Journal of Clinical Pharmacology, May 2012
CBD acts in some experimental models as an anti‐inflammatory, anticonvulsant, anti‐oxidant, anti‐emetic, anxiolytic and antipsychotic agent, and is therefore a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia, respectively.